Pennant Group, Inc. (PNTG) Stock
PNTG has an Alpha Score of 50 out of 100 (weak), computed on Nov 1, 2026 from 3 of 4 sub-scores. 5 of the hedge funds AlphaScala tracks reported PNTG in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $4.61M. Its trailing P/E ratio is 45.0 and its net margin 2.9% (key statistics as of Nov 1, 2026).
What is PNTG's Alpha Score?
How it works →Alpha Score of 50 reflects moderate overall profile with strong momentum, poor value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 1, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own PNTG?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 125K | $4.61M | -18% |
| D.E. Shaw David Shaw | 125K | $4.60M | -8% |
| Marshall Wace | 87K | $3.21M | -35% |
| Citadel Ken Griffin | 73K | $2.70M | +131% |
| Renaissance Technologies Jim Simons (founder) | 48K | $1.78M | -27% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Pennant Group, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 6, 26 | Cheney Kirk Sterling | EVP, GC and Corp Secy | SELL | 1.4K | $54K |
| Aug 6, 26 | Guerisoli Brent | Chief Executive Officer | SELL | 4.3K | $165K |
| Aug 6, 26 | Steik Jason Paul | Chief Clinical Officer | SELL | 1.4K | $54K |
SEC Form 4 filings as of Nov 6, 2026
See cluster-buy signals across all tickers →What are PNTG's key statistics?
Key statistics as of Nov 1, 2026
How does PNTG's valuation compare with the Healthcare sector?
| Metric | PNTG | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 45.0 | 28.8 | 113 |
| Net margin | 2.93% | 3.66% | 170 |
| Return on equity | 9.51% | 3.71% | 194 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 9, 2026). P/E excludes loss-making companies.
PNTG price chart
Powered by TradingViewWhat does Pennant Group, Inc. do?
Pennant Group, Inc. is a publicly traded healthcare company engaged in providing a range of post-acute healthcare services throughout the United States. Its primary function is to operate home health and hospice agencies, as well as senior living communities, dedicated to offering skilled nursing and housing services to elderly populations. The company particularly serves the needs of individuals requiring specialized care following hospitalizations or those managing chronic health conditions, thereby playing a significant role in the continuum of care for aging demographics. Notably, Pennant Group, Inc. impacts the healthcare and real estate sectors, given its combined focus on healthcare services and residential community management. It stands out for its decentralized service model designed to empower local leadership and maximize community engagement, thereby tailoring services to the specific needs of each location. In the financial market, Pennant Group, Inc. represents a blend of healthcare provision with an emphasis on home-based care solutions, reflecting broader industry trends towards personalized and localized healthcare delivery systems. As the demand for senior care services continues to rise amidst an aging population, the company holds an important place in addressing these evolving healthcare needs.